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Microbiology, Indraprastha Apollo Hospital, Sarita Vihar, New Delhi, IndiaAbstractEscherichia vulneris is an opportunistic human pathogen. It has been primarily reported in adult patients and invasive infections have been
observed in immune-suppressed individuals. This is the ﬁrst report of E. vulneris causing complicated diarrhoea and sepsis in an infant.
Two month old sick infant, born full-term, was admitted to the paediatrics department with loose motions and refusal to feed for four days. E.
vulneris was isolated from blood in pure culture. The isolate was characterized for diarrhoeal virulence markers: heat labile and heat stable
toxins (LT, ST) and hemolysin (hlyA) by PCR. The presence of LT enterotoxin and hemolysin provides strong evidence of the diarrhoeagenic
potential of E. vulneris, further leading to the invasive infection triggering sepsis.
As E. vulneris can lead to serious complications, an attempt should be made in clinical laboratories to identify and further characterize this new
Escherichia species.
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E-mail: rgaind5@hotmail.comCase reportA 2-month-old lethargic and sick female infant presented to the
Paediatrics Department with diarrhoea. She had been refusing
to breastfeed for 4 days before presentation and had no history
of fever, vomiting or seizures. There was no history of maternal
fever during the antenatal period. She was born full-term by
lower-segment caesarean section and the postnatal period was
uneventful. The infant was receiving bottle feeds. Physical ex-
amination revealed that the pulse and respiratory rates were
120/min and 51/min, respectively. She was dehydrated and
febrile with a temperature of 38.3°C (101°F). The neonatal
reﬂexes were poor along with a reduced muscle tone and low
activity. A probable diagnosis of acute gastroenteritis with© 2016 The Authors. Published by El
This is an open access artimoderate dehydration was made. The infant was admitted and
intravenous ﬂuids were administered. Her stool examination
and culture were unremarkable.
On day two of hospitalization, the infant developed high-
grade fever and repeated episodes of seizures. Laboratory in-
vestigations revealed haemoglobin of 163g/L, total leucocyte
count of 18.2 × 109/L and a platelet count of 572 × 109/L. The
level of serum calcium was slightly decreased to 1.9 mmol/L.
The qualitative C-reactive protein measurement was positive
(>10 mg/L). On day 3, blood and cerebrospinal ﬂuid samples
were sent for examination, querying the possibility of sepsis. An
empirical therapy for sepsis consisting of intravenous ampicillin
and amikacin was initiated. Cerebrospinal ﬂuid microscopy and
biochemical parameters were unremarkable and culture was
negative. Blood culture yielded pure growth of non-lactose
fermenting, motile, Gram-negative bacilli after 48 h of incuba-
tion. The colonies showed the presence of yellow pigment.
Biochemical tests revealed a positive catalase test and
exhibited glucose fermentation with production of gas in a
triple sugar iron agar differential medium. The isolate wasNew Microbe and New Infect 2016; 13: 83–86
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citrate utilization and Voges–Proskauer test. After 48 h of in-
cubation, an ortho-nitrophenyl-β-D-galactopyranoside test was
positive. The isolate was identiﬁed as Escherichia vulneris by
Vitek 2 Compact using ID GN card (BioMérieux, Marcy l’Etoile,
France) and Vitek MS (matrix-assisted laser desorption/ioniza-
tion time-of ﬂight mass spectrometry; BioMérieux) with a
conﬁdence value of 99.4. The identity of the isolate was further
conﬁrmed by 16s rRNA gene sequencing. A single isolated
colony from an overnight culture was used to perform a colony
PCR using universal primers 27F and 1492R. The PCR product
was run on gel and the amplicon of around 1400 bp was eluted.
The eluted DNA was further sequenced using a Sanger di-
deoxy sequencing method. The sequence obtained was
blasted using NCBI nucleotide blast. The blast results conﬁrmed
the isolate as E. vulneris. The sequence is submitted to NCBI
(Accession No. KX357823).
Antimicrobial susceptibility was performed by Kirby–
Bauer’s disc diffusion method as per the CLSI guidelines. The
isolate was extended spectrum β-lactamase negative and was
susceptible to ampicillin, amoxicillin-clavulanate, cephalosporins
(Cefuroxime, Cefoxitin, Ceftazidime and Cefotaxime), amino-
glycosides (gentamicin, amikacin and netilmicin), ciproﬂoxacin,
piperacillin-tazobactam, trimethoprim-sulphamethoxazole and
carbapenems (Imipenem, Meropenem, Ertapenem). Meanwhile,
a repeat blood culture after 24 h also yielded pure growth of
E. vulneris. Based on the susceptibility report, the initial therapy
was continued. After 7 days of the antibiotic treatment, the
infant improved clinically with lowering of fever, normal skin
turgor and a sucking reﬂex. The antibiotics were discontinued
on day 10 and the infant was discharged on oral feeds. Her
follow-up blood culture at the time of discharge was sterile.Molecular characterizationFIG. 1. Gel picture showing Escherichia vulneris positive for heat-labile
(LT) toxin (508 bp, Lane 1); hlyA toxin (1177 bp, Lane 2); and negative
for heat-stable (ST) toxin (Lane 3); PCRmixturewithout the template was
taken as a negative control (Lane 4); 100-bp ladder was used as a DNA
marker. PCR products were run on 1.8% agarose gel and visualized under
UV Transilluminator and pictured using a gel documentation system.The E. vulneris isolate was screened for virulence markers
encoding heat-labile (LT) and heat-stable (ST) enterotoxins [1]
and haemolysin (hlyA) [2] associated with diarrhoea and sepsis.
The DNA extracted from the culture grown overnight in
tryptic soy broth at 37°C in a CO2 incubator is used as tem-
plate. The primer sequences were: LT-F 50-GGCGACA-
GATTATACCGTGC-30; LT-R 50-CCGAATTCTGTTATATA
TGTC-30; ST-F 50-TTAATAGCACCCGGTACAAGCAGG-30;
ST-R 50-CTTGACTCTTCAAAAGAGAAAATTAC-30; hlyA F
50-AACAAGGATAAGCACTGTTCTGGCT-30; hlyA R 50-
ACCATATAAGCGGTCATTCCCGTCA-30.
The PCR for LT and ST toxin genes was performed using a
predeﬁned program with an initial denaturation at 95°C for
5 min, 35 cycles of denaturation at 95°C for 30 seconds,© 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microb
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceannealing at 56°C for 30 seconds, extension at 72°C for 45 min
and ﬁnal extension at 72° for 5 min with following primer pairs.
For haemolysin, the reaction conditions were initial denatur-
ation at 95° for 5 min, 35 cycles of denaturation at 95°C for 30
seconds, annealing at 55° for 30 seconds, extension at 72°C for
1 min and ﬁnal extension at 72° for 5 min. The isolate was
found to be positive for LT toxin and haemolysin (hlyA) but it
was negative for ST toxin (Fig. 1).DiscussionEscherichia vulneris is an opportunistic human pathogen and
there are limited clinical reports of human infections world-
wide [3–5]. A review of E. vulneris infections reported in
humans worldwide is presented in Table 1. In humans,
E. vulneris was initially isolated from infected wounds, in as-
sociation with other bacteria such as Staphylococcus aureus,
Staphylococcus epidermidis, streptococci, enterococci and
Enterobacter spp., Acinetobacter lwofﬁi and Cedecea neteri [4,6].
Later, E. vulneris was also isolated from other clinical speci-
mens, such as stool, sputum, urine, vaginal swabs and throat
swabs, where it was thought to be a colonizer [3]. As E. vulneris
failed to induce soft-tissue infections or lethality in mice on
pathogenicity testing, the clinical signiﬁcance of this species
was doubted [4]. However subsequent studies showed
E. vulneris as the sole pathogen in clinical cases of urosepsis,
osteomyelitis, intravenous catheter-related bacteraemia,iology and Infectious Diseases, NMNI, 13, 83–86
nses/by-nc-nd/4.0/).
TABLE 1. Review of human Escherichia vulneris infections reported so far
Year and place Age and sex Diagnosis Associated bacteria Immune status Source Treatment Outcome
1985, Hawaii [3] 12 cases Wound infection Heavy growth of
Staphylococcus aureus
NA NA NA NA
1991, California [6] 86 years, F Urosepsis Pure growth of E. vulneris Type II diabetes
mellitus
Urinary
catheter
Ampicillin-sulbactam Cured
1993, Spain [5] 2 cases Post-operative
wound infection
Post-operative peritonitis
Enterococcus faecium
Cedecea neteri
NA NA NA NA
1994, Massachusetts [8] 13 years, M Osteomyelitis Pure growth of E. vulneris Normal Wooden
foreign body
NA NA
1996, Massachusetts [9] 62 years, F Intravenous-catheter-related
bacteraemia
Pure growth of E. vulneris Poor nutrition;
Crohn’s disease
PICC line Cefazolin,
catheter removal
Cured
1997, Denmark [10] 14 years, M Infected soccer wound Bacillus cereus, CoNS,
non-haemolytic streptococci
Normal Not known Cefuroxime,
wound debridement
Cured
1999, Andhra Pradesh,
India [13]
12 cases Gastroenteritis Pure growth of E. vulneris NA NA NA NA
2005, Delhi, India [11] 4 years, F Meningitis Pure growth of E. vulneris Normal Nosocomial Piperacillin-tazobactam
and Meropenem
Cured
2006, Australia [12] 83 years, F CAPD-associated peritonitis Pure growth of E. vulneris Immune-suppressants
for myeloproliferative
disease
Peritoneal
catheter
Gentamicin Cured
2007, Tunisia [7] 70 years, M Bacteraemia following
subcutaneous abscess
Pure growth of E. vulneris Chronic lymphocytic
leukaemia
Abscess Ciproﬂoxacin and
Gentamicin
Cured
2008, Turkey [1] 64 years, M CAPD-associated peritonitis Pure growth of E. vulneris Chronic renal failure Not known Ceftriaxone Cured
Present case: 2013,
New Delhi, India
2 months, F Acute gastroenteritis and
sepsis
Pure growth of E. vulneris Normal Not known Ampicillin and
Amikacin
Cured
Note: NA, not available; M, male; F, female; PICC, peripherally inserted central catheter; CoNS, coagulase-negative staphylococci; CAPD, continuous ambulatory peritoneal dialysis.
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peritonitis and bacteraemia in a patient with chronic lympho-
cytic leukaemia [1,7–13]. Infections were primarily reported in
adults or elderly individuals and invasive infections were usu-
ally observed in immunosuppressed individuals. The source of
infection remains unclear.
Experimental studies on animals to ascertain the diar-
rhoeagenic potential of E. vulneris have been reported [14].
However, this is the ﬁrst report of E. vulneris causing compli-
cated diarrhoea with associated sepsis in an infant. Chaudhury
et al. studied enteropathogenicity in mice of new Escherichia
species isolated from 50 diarrhoeal stools (12 E. vulneris, six
Escherichia fergusonii, two Escherichia hermannii isolates). No
lethality was produced in mice; however, a signiﬁcant ﬂuid
accumulation in ileal loops was produced by E. vulneris. The
probable mechanism for enteropathogenicity was speculated
as enterotoxin production, though the role of other virulence
factors, such as adherence or invasiveness, could not be
excluded [14].
In the present case the 2-month-old infant presented with
acute gastroenteritis and subsequently developed early signs of
sepsis. There was no signiﬁcant maternal history and the natal
and postnatal periods were uneventful. As the stool culture was
negative for E. vulneris and other enteropathogens, we investi-
gated the isolate from the blood culture for the diarrhoeal and
other virulence markers. The presence of LT enterotoxin has
been reported for the ﬁrst time in a clinical isolate of E. vulneris
in this case.
In the absence of other possible source of infection like lung,
skin and soft-tissue and urinary tract infections and the use of© 2016 The Authors. Published by Elsevier Ltd on behal
This is an open access artican invasive device, we hypothesize that E. vulneris bacteraemia
apparently followed diarrhoea. The presence of the LT
enterotoxin and the haemolysin (hlyA) provides strong evidence
of the diarrhoeagenic potential of E. vulneris, further leading to
the invasive infection triggering sepsis. Microbial contamination
of food and water are the major causes of childhood diarrhoea.
As the infant was not exclusively breastfed, exposure to the
contaminated formula top-up feed may be the source of
infection. The other probable sources of contamination include
the immediate environmental ﬂora including maternal ﬂora or
contaminated water used for formulation of top-up feed.
Moreover children under the age of 2 years are more predis-
posed to infections because of their under-developed gastro-
intestinal tract immune system, impaired spleen, B lymphocytes
and T-cell helper functions, which are important mechanisms
for combating microbial attack. In addition, the levels of IgA,
essential for combating microbial infections in the gastrointes-
tinal tract are also drastically reduced in children.
As in previous reports, the E. vulneris isolated from the
present case was a pan-sensitive strain (susceptible to all classes
of antimicrobials tested) [3,7,8,13]. Rarely, resistance to ampi-
cillin and/or ﬁrst- and second-generation cephalosporins,
chloramphenicol and tetracycline has been reported [4,12,14];
however, there is a single clinical report of extended spectrum
β-lactamase producing E. vulneris [12].
In conclusion, we report E. vulneris as a potential diarrhoeal
pathogen in infants and young children that may be associated
with serious complications such as sepsis. An attempt should be
made in clinical laboratories to identify and further characterize
this rare Escherichia species.f of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 13, 83–86
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